The neurobiology of neurooncology

被引:37
作者
Read, Tracy-Ann
Hegedus, Balazs
Wechsler-Reya, Robert
Gutmann, David H.
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA
[3] Univ Bergen, Dept Biomed, Bergen, Norway
关键词
D O I
10.1002/ana.20912
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The histological classification of brain tumors currently is based on the morphological appearance and protein expression patterns that reflect specific cell types within the central nervous system. Recent studies have suggested that the cells of origin for brain tumors may persist in the fully formed tumors, and that these "cancer stem cells" might represent the relevant cellular targets for anticancer therapy. In this regard, insights into the developmental neurobiology of brain tumors has significant impact on our understanding of the molecular and cellular pathogenesis of these devastating cancers, as well as the development of new strategies for treating brain tumors.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 86 条
[1]   In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog [J].
Ahn, S ;
Joyner, AL .
NATURE, 2005, 437 (7060) :894-897
[2]  
Altman J., 1997, RELATION ITS EVOLUTI
[3]   Epidermal growth factor receptor and Ink4a/Arf:: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis [J].
Bachoo, RM ;
Maher, EA ;
Ligon, KL ;
Sharpless, NE ;
Chan, SS ;
You, MJJ ;
Tang, Y ;
DeFrances, J ;
Stover, E ;
Weissleder, R ;
Rowitch, DH ;
Louis, DN ;
DePinho, RA .
CANCER CELL, 2002, 1 (03) :269-277
[4]   Medulloblastoma cerebelli - A common type of midcerebellar glioma of childhood [J].
Bailey, P ;
Cushing, H .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1925, 14 (02) :192-224
[5]  
Bailey PCH., 1926, CLASSIFICATION TUMOR
[6]  
Bajenaru ML, 2003, CANCER RES, V63, P8573
[7]   Platelet-derived growth factor receptor (PDGFR): A target for anticancer therapeutics [J].
Board, R ;
Jayson, GC .
DRUG RESISTANCE UPDATES, 2005, 8 (1-2) :75-83
[8]  
Bühren J, 2000, J NEUROPATH EXP NEUR, V59, P229
[9]  
DAHLSTRAND J, 1992, CANCER RES, V52, P5334
[10]  
Dahmane N, 1999, DEVELOPMENT, V126, P3089